ADIPOQ and metabolic dysfunction-associated steatohepatitis: Two smaller studies, however, yielded contradictory results, as they found that hepatic expressions of adiponectin mRNA and adipoR2 receptor were significantly lower in NASH patients compared with patients with fatty liver [81, 82].